| Christian Michelle Williams, PHARMD | |
|
304 Baptiste Dr, Paola, KS 66071-1327 | |
| (913) 294-2715 | |
| Not Available |
| Full Name | Christian Michelle Williams |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 304 Baptiste Dr, Paola, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770205486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-107017 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christian Michelle Williams, PHARMD 304 Baptiste Dr, Paola, KS 66071-1327 Ph: (913) 294-2715 | Christian Michelle Williams, PHARMD 304 Baptiste Dr, Paola, KS 66071-1327 Ph: (913) 294-2715 |
News Archive
A new study from the University of Turku, Finland, shows that intracellular receptor signalling sustains cancer cells that have detached from the surrounding tissue. When the signalling is prevented, the cells cannot spread to other parts of the body. This significant research result influences how cancer research is directed in the future.
A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.
A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.
Chelsea Therapeutics International, Ltd. announced today its intention, subject to market and other conditions, to offer $35 million in shares of its common stock in a registered public offering pursuant to its existing shelf registration statement.
Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.
› Verified 9 days ago
Anna-maria Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 N Hospital Dr, Paola, KS 66071 Phone: 913-294-3516 Fax: 913-294-8411 | |
Emigene Brown, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Baptiste Dr, Paola, KS 66071 Phone: 913-294-9125 | |
Steven Michael Stoecker, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 310 Hedge Ln, Paola, KS 66071 Phone: 913-294-2433 Fax: 913-294-0815 | |
Nathan Rockers, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 304 Baptiste Dr, Paola, KS 66071 Phone: 913-294-2715 | |
Melissa Gilkison, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Baptiste Dr, Paola, KS 66071 Phone: 913-294-9125 | |
Chelsea Doherty, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 N Hospital Dr, Paola, KS 66071 Phone: 913-294-3516 | |
Dr. Jihan Widad Gallegos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 311 N Hospital Dr, Paola, KS 66071 Phone: 913-294-3516 |